ACT

July. 13/2016

Top 5 Stories

Brexit Result Creates Huge Uncertainty for EMA, Drug Developers

The Brexit Effect

advertisment

Learn how to unlock the full potential of Risk-Based Monitoring (RBM) using a signal-driven approach that empowers efficient, informed decisions to dramatically improve trial safety, quality and compliance – in a way that is traceable and auditable. Listen to the podcast now

4 Steps to Mitigate Screen Failure Risks

Are Phase III Clinical Trials Really Consistently Behind Schedule?

Gotcha! Punitive Action for Bent Drug Promotion

advertisment

Transforming Patient Recruitment through Patient and Site Engagement
Live Webinar: Tuesday, August 23, 2016 at 11 am – 12 noon EDT
Register now

Trending on Social Media

mHealth Clinical Trial Measures Sleep Outcomes

Q&A: Research Data Promise vs. Reality

Preparing for the ICH E6 (R2) Addendum: Part 3 of 3


Get the full picture

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Watch ACT TV for interviews with
Clinical Trials Experts


Ask the editor

Lisa Henderson
Editor in Chief
lhenderson@advanstar.com

Advertise

Mike Tessalone
Publisher
Mtessalone@advanstar.com